Published in Cancer Weekly, November 30th, 1998
R. Lupetti and colleagues from the National Cancer Institute, Italy, reported the identification of a new shared human melanoma antigen that is recognized by a human leukocyte antigen (HLA)-A*68011-restricted cytotoxic T lymphocyte clone (CTL 128) ("Translation of a Retained Intron in Tyrosinase-Related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-Defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage," Journal of Experimental Medicine, September 21, 1998;188(6):1005-1016).
"The cDNA encoding this antigen is composed of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.